We are honored to announce that Prof. Dr. Seza Özen who is the member of Honorary Advisory Board of JBACHS has already won the Aziz Sancar Science Award of TUSEB.
We are happy to announce that The Journal of Basic and Clinical Health Sciences (JBACHS) is indexed by the Emerging Sources Citation Index since November 2017, and indexed by the Ulakbim-TR since 2017.
Journal of Basic and Clinical Health Sciences 2020 , Vol 4 , Issue 1
A Case Report of a Pregnant Woman with Chronic Hepatit B: Use of Tenofovir in Pregnancy
Hülya Güven1,M. Aylin Arıcı2,Gözde Aktürk2,Özge Güner2
1Istanbul Yeni Yuzyil University, Medical Pharmacology, Istanbul, Turkey
2Dokuz Eylul University, Medical Pharmacology, Izmir, Turkey
DOI : 10.30621/jbachs.2020.807 Objective: To overview the effects of tenofovir use in chronic Hepatit B in pregnancy and asses the effects on the vertical transmission of HBV from mother to baby.

Case Report: We presented a pregnant woman who has Chronic Hepatit B with high viral load in the 26th week of her pregnancy. She took tenofovir in the 37th week of her pregnancy once a day along six days. Then she gave birth to a healthy baby at the 37th week of the pregnancy. Hepatit B Immunoglobulin (HBIG) and Hepatit B vaccine had applied to the baby. In the follow-up, the mother"s viral load was decreased. HBV DNA was not detected in the baby.

Conclusion: Only six-day tenofovir use in this pregnant woman with chronic Hepatit B may contribute to preventing vertical transmission of HBV from mother to baby. However, the importance of HBIG and vaccination should not be forgotten. Keywords : Tenofovir, chronic Hepatit B, pregnancy, vertical transmission